Calithera Biosciences (CALA) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CALA vs. SMFL, AMPE, PXMD, CLVR, EFTR, HSTO, ONCSQ, ATNFW, LBPSW, and AEHAWShould you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Smart for Life (SMFL), Ampio Pharmaceuticals (AMPE), PaxMedica (PXMD), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), Histogen (HSTO), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), and Aesther Healthcare Acquisition (AEHAW). These companies are all part of the "pharmaceutical products" industry. Calithera Biosciences vs. Its Competitors Smart for Life Ampio Pharmaceuticals PaxMedica Clever Leaves eFFECTOR Therapeutics Histogen OncoSec Medical 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Calithera Biosciences (NASDAQ:CALA) and Smart for Life (NASDAQ:SMFL) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Which has more volatility & risk, CALA or SMFL? Calithera Biosciences has a beta of -2.55, meaning that its stock price is 355% less volatile than the S&P 500. Comparatively, Smart for Life has a beta of 17.06, meaning that its stock price is 1,606% more volatile than the S&P 500. Which has better valuation & earnings, CALA or SMFL? Smart for Life has higher revenue and earnings than Calithera Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalithera BiosciencesN/AN/A-$39.65MN/AN/ASmart for Life$11.11M0.00-$22.68MN/AN/A Does the media refer more to CALA or SMFL? In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled Smart for Life'saverage media sentiment score. Company Overall Sentiment Calithera Biosciences Neutral Smart for Life Neutral Do insiders and institutionals hold more shares of CALA or SMFL? 28.4% of Smart for Life shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by insiders. Comparatively, 31.7% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is CALA or SMFL more profitable? Company Net Margins Return on Equity Return on Assets Calithera BiosciencesN/A N/A N/A Smart for Life N/A N/A N/A SummarySmart for Life beats Calithera Biosciences on 5 of the 5 factors compared between the two stocks. Get Calithera Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CALA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart CALA vs. The Competition Export to ExcelMetricCalithera BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$840.62M$5.80B$10.16BDividend YieldN/A4.84%5.72%4.60%P/E RatioN/A1.1475.2426.40Price / SalesN/A26.51513.38175.37Price / CashN/A19.5625.8129.91Price / BookN/A6.6613.606.28Net Income-$39.65M-$4.13M$3.29B$270.38M Calithera Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CALACalithera BiosciencesN/AN/AN/AN/A$0.00N/A0.0060Gap DownSMFLSmart for LifeN/A$0.00-87.5%N/A-99.9%$4K$11.11M0.00110Gap UpAMPEAmpio PharmaceuticalsN/A$0.00flatN/A+22.7%$3KN/A0.0020PXMDPaxMedicaN/A$0.00flatN/A-99.9%$2KN/A0.002CLVRClever LeavesN/A$0.00flatN/A+100.0%$1K$17.42M0.00560Gap UpEFTReFFECTOR Therapeutics0.1255 of 5 stars$0.00flatN/A-99.6%$1KN/A0.0010HSTOHistogenN/A$0.00flatN/A-99.9%$1K$19K0.0020ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040ATNFW180 Life SciencesN/A$0.18+0.1%N/A+1,107.9%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002 Related Companies and Tools Related Companies SMFL Competitors AMPE Competitors PXMD Competitors CLVR Competitors EFTR Competitors HSTO Competitors ONCSQ Competitors ATNFW Competitors LBPSW Competitors AEHAW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CALA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calithera Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calithera Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALA Stock Alerts